Identification of type III secretion substrates of Chlamydia trachomatis using Yersinia enterocolitica as a heterologous system

BMC Microbiology

Volumn 14, Issue 1, 2014, Pages

  Da Cunha, Maria ^a,c   Milho, Catarina ^a,d   Almeida, Filipe ^a,c   Pais, Sara V ^a,c   Borges, Vítor ^b   Maurício, Rui ^a,e   Borrego, Maria José ^b   Gomes, João Paulo ^b   Mota, Luís Jaime ^a,c  

^a INSTITUTO DE TECNOLOGIA QUÍMICA E BIOLÓGICA   (Portugal)

^b NATIONAL INSTITUTE OF HEALTH DR RICARDO JORGE   (Portugal)

^c UNIVERSIDADE NOVA DE LISBOA   (Portugal)

^d UNIVERSITY OF MINHO   (Portugal)

^e ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Bacterial pathogenesis; Chlamydia; Effectors; Type III secretion; Yersinia

Indexed keywords

AMINO ACID; BACTERIAL PROTEIN; BETA LACTAMASE TEM 1; T3S SUBSTRATE PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL GENOME; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; CHLAMYDIA TRACHOMATIS; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC CODE; HOST CELL; HUMAN; HUMAN CELL; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; SECRETORY PATHWAY; TYPE III SECRETION SYSTEM; YERSINIA ENTEROCOLITICA;

BACTERIA (MICROORGANISMS); CHLAMYDIA; CHLAMYDIA TRACHOMATIS; YERSINIA; YERSINIA ENTEROCOLITICA;

BACTERIAL SECRETION SYSTEMS; CHLAMYDIA TRACHOMATIS; CLONING, MOLECULAR; EPITHELIAL CELLS; GENE EXPRESSION; HELA CELLS; HUMANS; PROTEIN TRANSPORT; VIRULENCE FACTORS; YERSINIA ENTEROCOLITICA;

EID: 84896714285     PISSN: None     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-14-40     Document Type: Article

References (78)

1. Trachoma. Wright HR, Turner A, Taylor HR, Lancet 2008 371 9628 1945 1954 (Pubitemid 351778193)
2. Genital Chlamydia trachomatis infections. Bebear C, de Barbeyrac B, Clin Microbiol Infect 2009 15 1 4 10
3. The chlamydial developmental cycle. Abdelrahman YM, Belland RJ, FEMS Microbiol Rev 2005 29 5 949 959 (Pubitemid 41416845)
4. Effector protein modulation of host cells: examples in the Chlamydia spp. arsenal. Betts HJ, Wolf K, Fields KA, Curr Opin Microbiol 2009 12 1 81 87
5. Chlamydia effector proteins and new insights into chlamydial cellular microbiology. Valdivia RH, Curr Opin Microbiol 2008 11 1 53 59
6. The conserved Tarp actin binding domain is important for chlamydial invasion. Jewett TJ, Miller NJ, Dooley CA, Hackstadt T, PLoS Pathog 2010 6 7 1000997
7. Chlamydial entry involves TARP binding of guanine nucleotide exchange factors. Lane BJ, Mutchler C, Al Khodor S, Grieshaber SS, Carabeo RA, PLoS Pathog 2008 4 3 1000014
8. Chlamydia trachomatis inclusion membrane protein CT228 recruits elements of the myosin phosphatase pathway to regulate release mechanisms. Lutter EI, Barger AC, Nair V, Hackstadt T, Cell Rep 2013 3 6 1921 1931
9. Mammalian 14-3-3beta associates with the Chlamydia trachomatis inclusion membrane via its interaction with IncG. Scidmore MA, Hackstadt T, Mol Microbiol 2001 39 6 1638 1650 (Pubitemid 32269759)
10. SNARE protein mimicry by an intracellular bacterium. Delevoye C, Nilges M, Dehoux P, Paumet F, Perrinet S, Dautry-Varsat A, Subtil A, PLoS Pathog 2008 4 3 1000022
11. The GTPase Rab4 interacts with Chlamydia trachomatis inclusion membrane protein CT229. Rzomp KA, Moorhead AR, Scidmore MA, Infect Immun 2006 74 9 5362 5373 (Pubitemid 44300456)
12. Specific chlamydial inclusion membrane proteins associate with active Src family kinases in microdomains that interact with the host microtubule network. Mital J, Miller NJ, Fischer ER, Hackstadt T, Cell Microbiol 2010 12 9 1235 1249
13. Human GCIP interacts with CT847, a novel Chlamydia trachomatis type III secretion substrate, and is degraded in a tissue-culture infection model. Chellas-Gery B, Linton CN, Fields KA, Cell Microbiol 2007 9 10 2417 2430 (Pubitemid 47365647)
14. Evidence that CT694 is a novel Chlamydia trachomatis T3S substrate capable of functioning during invasion or early cycle development. Hower S, Wolf K, Fields KA, Mol Microbiol 2009 72 6 1423 1437
15. Histone methylation by NUE, a novel nuclear effector of the intracellular pathogen Chlamydia trachomatis. Pennini ME, Perrinet S, Dautry-Varsat A, Subtil A, PLoS Pathog 2010 6 7 1000995
16. The lipid transfer protein CERT interacts with the Chlamydia inclusion protein IncD and participates to ER-Chlamydia inclusion membrane contact sites. Derre I, Swiss R, Agaisse H, PLoS Pathog 2011 7 6 1002092
17. Development of a transformation system for Chlamydia trachomatis: restoration of glycogen biosynthesis by acquisition of a plasmid shuttle vector. Wang Y, Kahane S, Cutcliffe LT, Skilton RJ, Lambden PR, Clarke IN, PLoS Pathog 2011 7 9 1002258
18. Dendrimer-enabled DNA delivery and transformation of Chlamydia pneumoniae. Gerard HC, Mishra MK, Mao G, Wang S, Hali M, Whittum-Hudson JA, Kannan RM, Hudson AP, Nanomedicine 2013 9 7 996 1008
19. Multifunctional analysis of Chlamydia-specific genes in a yeast expression system. Sisko JL, Spaeth K, Kumar Y, Valdivia RH, Mol Microbiol 2006 60 1 51 66 (Pubitemid 43363287)
20. The Salmonella enterica serovar Typhimurium-encoded type III secretion systems can translocate Chlamydia trachomatis proteins into the cytosol of host cells. Ho TD, Starnbach MN, Infect Immun 2005 73 2 905 911 (Pubitemid 40165749)
21. A directed screen for chlamydial proteins secreted by a type III mechanism identifies a translocated protein and numerous other new candidates. Subtil A, Delevoye C, Balana ME, Tastevin L, Perrinet S, Dautry-Varsat A, Mol Microbiol 2005 56 6 1636 1647 (Pubitemid 40780657)
22. Identification of a family of effectors secreted by the type III secretion system that are conserved in pathogenic Chlamydiae. Muschiol S, Boncompain G, Vromman F, Dehoux P, Normark S, Henriques-Normark B, Subtil A, Infect Immun 2011 79 2 571 580
23. The chlamydial OTU domain-containing protein ChlaOTU is an early type III secretion effector targeting ubiquitin and NDP52. Furtado AR, Essid M, Perrinet S, Balana ME, Yoder N, Dehoux P, Subtil A, Cell Microbiol 2013 15 12 2064 2079
24. Evidence for the secretion of Chlamydia trachomatis CopN by a type III secretion mechanism. Fields KA, Hackstadt T, Mol Microbiol 2000 38 5 1048 1060 (Pubitemid 32009679)
25. A chlamydial type III translocated protein is tyrosine-phosphorylated at the site of entry and associated with recruitment of actin. Clifton DR, Fields KA, Grieshaber SS, Dooley CA, Fischer ER, Mead DJ, Carabeo RA, Hackstadt T, Proc Natl Acad Sci U S A 2004 101 27 10166 10171 (Pubitemid 38891213)
26. Identification of novel type III secretion chaperone-substrate complexes of Chlamydia trachomatis. Pais SV, Milho C, Almeida F, Mota LJ, PLoS ONE 2013 8 2 56292
27. Genus-optimized strategy for the identification of chlamydial type III secretion substrates. Hovis KM, Mojica S, McDermott JE, Pedersen L, Simhi C, Rank RG, Myers GS, Ravel J, Hsia RC, Bavoil PM, Pathog Dis 2013 69 3 213 222
28. Sequence-based prediction of type III secreted proteins. Arnold R, Brandmaier S, Kleine F, Tischler P, Heinz E, Behrens S, Niinikoski A, Mewes HW, Horn M, Rattei T, PLoS Pathog 2009 5 4 1000376
29. Accurate prediction of secreted substrates and identification of a conserved putative secretion signal for type III secretion systems. Samudrala R, Heffron F, McDermott JE, PLoS Pathog 2009 5 4 1000375
30. Prediction of type III secretion signals in genomes of gram-negative bacteria. Lower M, Schneider G, PLoS One 2009 4 6 5917
31. CD8+ T cells recognize an inclusion membrane-associated protein from the vacuolar pathogen Chlamydia trachomatis. Fling SP, Sutherland RA, Steele LN, Hess B, D'Orazio SE, Maisonneuve J, Lampe MF, Probst P, Starnbach MN, Proc Natl Acad Sci U S A 2001 98 3 1160 1165 (Pubitemid 32121203)
32. Identification of Chlamydia trachomatis CT621, a protein delivered through the type III secretion system to the host cell cytoplasm and nucleus. Hobolt-Pedersen AS, Christiansen G, Timmerman E, Gevaert K, Birkelund S, FEMS Immunol Med Microbiol 2009 57 1 46 58
33. The obligate intracellular pathogen Chlamydia trachomatis targets host lipid droplets. Kumar Y, Cocchiaro J, Valdivia RH, Curr Biol 2006 16 16 1646 1651 (Pubitemid 44233270)
34. Characterization of fifty putative inclusion membrane proteins encoded in the Chlamydia trachomatis genome. Li Z, Chen C, Chen D, Wu Y, Zhong Y, Zhong G, Infect Immun 2008 76 6 2746 2757
35. Localization of Chlamydia trachomatis hypothetical protein CT311 in host cell cytoplasm. Lei L, Qi M, Budrys N, Schenken R, Zhong G, Microb Pathog 2011 51 3 101 109
36. Chlamydia trachomatis secretion of hypothetical protein CT622 into host cell cytoplasm via a secretion pathway that can be inhibited by the type III secretion system inhibitor compound 1. Gong S, Lei L, Chang X, Belland R, Zhong G, Microbiology 2011 157 Pt 4 1134 1144
37. Chlamydia trachomatis secretion of an immunodominant hypothetical protein (CT795) into host cell cytoplasm. Qi M, Lei L, Gong S, Liu Q, DeLisa MP, Zhong G, J Bacteriol 2011 193 10 2498 2509
38. Chlamydia trachomatis GlgA Is Secreted into Host Cell Cytoplasm. Lu C, Lei L, Peng B, Tang L, Ding H, Gong S, Li Z, Wu Y, Zhong G, PLoS ONE 2013 8 7 68764
39. The chlamydial plasmid-encoded protein pgp3 is secreted into the cytosol of Chlamydia-infected cells. Li Z, Chen D, Zhong Y, Wang S, Zhong G, Infect Immun 2008 76 8 3415 3428
40. Identification of a novel nuclear localization signal sequence in Chlamydia trachomatis-secreted hypothetical protein CT311. Lei L, Dong X, Li Z, Zhong G, PLoS ONE 2013 8 5 64529
41. Chlamydia trachomatis-derived deubiquitinating enzymes in mammalian cells during infection. Misaghi S, Balsara ZR, Catic A, Spooner E, Ploegh HL, Starnbach MN, Mol Microbiol 2006 61 1 142 150
42. ChlaDub1 of Chlamydia trachomatis suppresses NF-kappaB activation and inhibits IkappaBalpha ubiquitination and degradation. Le Negrate G, Krieg A, Faustin B, Loeffler M, Godzik A, Krajewski S, Reed JC, Cell Microbiol 2008 10 9 1879 1892
43. Cultivation and laboratory maintenance of Chlamydia trachomatis. Scidmore MA, Curr Protoc Microbiol 2005 00:11A.1.1-11A.1.25
44. YopT, a new Yersinia Yop effector protein, affects the cytoskeleton of host cells. Iriarte M, Cornelis GR, Mol Microbiol 1998 29 3 915 929 (Pubitemid 28365476)
45. Polymorphisms in Inc proteins and differential expression of inc genes among Chlamydia trachomatis strains correlate with invasiveness and tropism of lymphogranuloma venereum isolates. Almeida F, Borges V, Ferreira R, Borrego MJ, Gomes JP, Mota LJ, J Bacteriol 2012 194 23 6574 6585
46. YscU recognizes translocators as export substrates of the Yersinia injectisome. Sorg I, Wagner S, Amstutz M, Muller SA, Broz P, Lussi Y, Engel A, Cornelis GR, EMBO J 2007 26 12 3015 3024 (Pubitemid 46975780)
47. Identification of the secretion and translocation domain of the enteropathogenic and enterohemorrhagic Escherichia coli effector Cif, using TEM-1 beta-lactamase as a new fluorescence-based reporter. Charpentier X, Oswald E, J Bacteriol 2004 186 16 5486 5495 (Pubitemid 39038151)
48. Genetic analysis of the formation of the Ysc-Yop translocation pore in macrophages by Yersinia enterocolitica: role of LcrV, YscF and YopN. Marenne MN, Journet L, Mota LJ, Cornelis GR, Microb Pathog 2003 35 6 243 258 (Pubitemid 37346163)
49. Effect of low- and high-virulence Yersinia enterocolitica strains on the inflammatory response of human umbilical vein endothelial cells. Denecker G, Totemeyer S, Mota LJ, Troisfontaines P, Lambermont I, Youta C, Stainier I, Ackermann M, Cornelis GR, Infect Immun 2002 70 7 3510 3520 (Pubitemid 34665987)
50. Role of Yops and adhesins in resistance of Yersinia enterocolitica to phagocytosis. Grosdent N, Maridonneau-Parini I, Sory MP, Cornelis GR, Infect Immun 2002 70 4165 4176 (Pubitemid 34790925)
51. The discovery of SycO highlights a new function for type III secretion effector chaperones. Letzelter M, Sorg I, Mota LJ, Meyer S, Stalder J, Feldman M, Kuhn M, Callebaut I, Cornelis GR, EMBO J 2006 25 13 3223 3233 (Pubitemid 44106772)
52. Normalization strategies for real-time expression data in Chlamydia trachomatis. Borges V, Ferreira R, Nunes A, Nogueira P, Borrego MJ, Gomes JP, J Microbiol Methods 2010 82 3 256 264
53. Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis. Stephens RS, Kalman S, Lammel C, Fan J, Marathe R, Aravind L, Mitchell W, Olinger L, Tatusov RL, Zhao Q, et al. Science 1998 282 5389 754 759 (Pubitemid 28489390)
54. Chlamydia trachomatis: genome sequence analysis of lymphogranuloma venereum isolates. Thomson NR, Holden MT, Carder C, Lennard N, Lockey SJ, Marsh P, Skipp P, O'Connor CD, Goodhead I, Norbertzcak H, et al. Genome Res 2008 18 1 161 171
55. Chlamydia trachomatis protein GrgA activates transcription by contacting the nonconserved region of sigma66. Bao X, Nickels BE, Fan H, Proc Natl Acad Sci U S A 2012 109 42 16870 16875
56. T3-MM: a Markov model effectively classifies bacterial type III secretion signals. Wang Y, Sun M, Bao H, White AP, PLoS ONE 2013 8 3 58173
57. Identification of the YopE and YopH domains required for secretion and internalization into the cytosol of macrophages, using the cyaA gene fusion approach. Sory MP, Boland A, Lambermont I, Cornelis GR, Proc Natl Acad Sci U S A 1995 92 26 11998 12002 (Pubitemid 26013998)
58. Yersinia YopE is targeted for type III secretion by N-terminal, not mRNA, signals. Lloyd SA, Norman M, Rosqvist R, Wolf-Watz H, Mol Microbiol 2001 39 2 520 531 (Pubitemid 32113521)
59. SycE allows secretion of YopE-DHFR hybrids by the Yersinia enterocolitica type III Ysc system. Feldman MF, Muller S, Wuest E, Cornelis GR, Mol Microbiol 2002 46 4 1183 1197 (Pubitemid 35370603)
60. Yop fusions to tightly folded protein domains and their effects on Yersinia enterocolitica type III secretion. Lee VT, Schneewind O, J Bacteriol 2002 184 13 3740 3745 (Pubitemid 34625685)
61. Chaperone release and unfolding of substrates in type III secretion. Akeda Y, Galan JE, Nature 2005 437 7060 911 915 (Pubitemid 41486769)
62. Rejection of impassable substrates by Yersinia type III secretion machines. Sorg JA, Miller NC, Marketon MM, Schneewind O, J Bacteriol 2005 187 20 7090 7102 (Pubitemid 41428886)
63. The type III secretion injectisome. Cornelis GR, Nat Rev Microbiol 2006 4 11 811 825 (Pubitemid 44593948)
64. Maintenance of an unfolded polypeptide by a cognate chaperone in bacterial type III secretion. Stebbins CE, Galan JE, Nature 2001 414 6859 77 81 (Pubitemid 33041626)
65. Chlamydia trachomatis plasmid-encoded Pgp4 is a transcriptional regulator of virulence-associated genes. Song L, Carlson JH, Whitmire WM, Kari L, Virtaneva K, Sturdevant DE, Watkins H, Zhou B, Sturdevant GL, Porcella SF, et al. Infect Immun 2013 81 3 636 644
66. Unraveling the basic biology and clinical significance of the chlamydial plasmid. Rockey DD, J Exp Med 2011 208 11 2159 2162
67. A live-attenuated chlamydial vaccine protects against trachoma in nonhuman primates. Kari L, Whitmire WM, Olivares-Zavaleta N, Goheen MM, Taylor LD, Carlson JH, Sturdevant GL, Lu C, Bakios LE, Randall LB, et al. J Exp Med 2011 208 11 2217 2223
68. Immunization with the attenuated plasmidless Chlamydia trachomatis L2(25667R) strain provides partial protection in a murine model of female genitourinary tract infection. Olivares-Zavaleta N, Whitmire W, Gardner D, Caldwell HD, Vaccine 2010 28 6 1454 1462
69. Whole-genome analysis of diverse Chlamydia trachomatis strains identifies phylogenetic relationships masked by current clinical typing. Harris SR, Clarke IN, Seth-Smith HM, Solomon AW, Cutcliffe LT, Marsh P, Skilton RJ, Holland MJ, Mabey D, Peeling RW, et al. Nat Genet 2012 44 4 413 419 S411
70. The Chlamydia type III secretion system C-ring engages a chaperone-effector protein complex. Spaeth KE, Chen YS, Valdivia RH, PLoS Pathog 2009 5 9 1000579
71. Chlamydial homologues of the MACPF (MAC/perforin) domain. Ponting CP, Curr Biol 1999 9 24 911 R913
72. Biological characterization of Chlamydia trachomatis plasticity zone MACPF domain family protein CT153. Taylor LD, Nelson DE, Dorward DW, Whitmire WM, Caldwell HD, Infect Immun 2010 78 6 2691 2699
73. Modulation of virulence factor expression by pathogen target cell contact. Pettersson J, Nordfelth R, Dubinina E, Bergman T, Gustafsson M, Magnusson KE, Wolf-Watz H, Science 1996 273 5279 1231 1233 (Pubitemid 26293214)
74. A secreted anti-activator, OspD1, and its chaperone, Spa15, are involved in the control of transcription by the type III secretion apparatus activity in Shigella flexneri. Parsot C, Ageron E, Penno C, Mavris M, Jamoussi K, d'Hauteville H, Sansonetti P, Demers B, Mol Microbiol 2005 56 6 1627 1635 (Pubitemid 40780656)
75. MxiC is secreted by and controls the substrate specificity of the Shigella flexneri type III secretion apparatus. Botteaux A, Sory MP, Biskri L, Parsot C, Allaoui A, Mol Microbiol 2009 71 2 449 460
76. The multitalented type III chaperones: all you can do with 15 kDa. Feldman MF, Cornelis GR, FEMS Microbiol Lett 2003 219 2 151 158 (Pubitemid 36302591)
77. The various and varying roles of specific chaperones in type III secretion systems. Parsot C, Hamiaux C, Page AL, Curr Opin Microbiol 2003 6 1 7 14 (Pubitemid 36258530)
78. A C. trachomatis cloning vector and the generation of C. trachomatis strains expressing fluorescent proteins under the control of a C. trachomatis promoter. Agaisse H, Derre I, PLoS ONE 2013 8 2 57090